Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Newtopia in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.00.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Newtopia. This N/A consensus rating has held steady for over two years.
Newtopia
Newtopia Inc. operates as a tech-enabled whole health platform in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. The company was incorporated in 2008 and is headquartered in Toronto, Canada.
Read More